{"api":"v1","generated_at":"2026-10-02T17:36:43.652Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-tdn-grade-d68ee5","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-tdn-grade-d68ee5/at/2026-10-02T12-31Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-02T12:31:46.748Z","snapshot_stamp":"2026-10-02T12-31Z","endpoint":{"slug":"api-magentlab-com-api-calc-tdn-grade-d68ee5","canonical_url":"https://api.magentlab.com/api/calc/tdn_grade","resource":"https://api.magentlab.com/api/calc/tdn_grade","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Terrapon 2021 Therapy-Disability-Neurology (TDN) grade. Caller assigns therapy t1-t5, modified Rankin 0-6 (6 is death), and new neurologic deficit. Overall grade is max(T, D, N); t5 or mRS 6 is always 5. D maps mRS 0-1→1, 2-3→2, 4→3, 5→4, 6→5; new deficit is N=2 else N=1. Not a diagnosis and not Clavien-Dindo alone. magent does not grade the event.","service_name":"magent","declared_category":null,"declared_tags":["tdn-grade","neurosurgery","adverse-event","neurology","calculator"],"route_template":null,"registry_updated":"2026-09-28T14:59:38.507Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc tdn grade","category":"search","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-02T12:31:46.748Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-02T12:31:46.748Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T14:59:38.363Z"},"validation":{"latest":{"observed_at":"2026-10-02T16:52:36.313Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-02"},"uptime":[{"days":7,"observed":5,"passed":5,"ratio":1},{"days":30,"observed":5,"passed":5,"ratio":1},{"days":90,"observed":5,"passed":5,"ratio":1}],"history_90d":[{"observed_at":"2026-10-02T16:52:36.313Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-02","state_changed":false},{"observed_at":"2026-10-01T09:34:08.069Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T09:02:16.492Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T21:07:24.380Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:49:27.042Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["tdn-grade","neurosurgery","adverse-event","neurology","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/tdn_grade","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T14:59:38.363Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/tdn_grade","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"therapy":"t1","disability_mrs":0,"new_neurologic_deficit":false},{"therapy":"t1","disability_mrs":0,"new_neurologic_deficit":false}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/tdn_grade","count":2,"items":[{"formula":"tdn_grade","citation":{"id":"terrapon-2021","doi":"10.1093/neuros/nyab121","pmid":"33887774","title":"Adverse Events in Neurosurgery: The Novel Therapy-Disability-Neurology Grade","source":"Neurosurgery. 2021;89(2):236-245","authors":"Terrapon APR, Zattra CM, Voglis S, et al."},"criteria":[{"met":true,"value":1,"factor":"therapy"},{"met":true,"value":1,"factor":"disability"},{"met":true,"value":1,"factor":"neurology"}],"tdn_grade":1,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","therapy_grade":1,"neurology_grade":1,"disability_grade":1,"formula_expression":"tdn_grade = max(T, D, N); T is therapy t1-t5 (t1 no treatment beyond antiemetics, antipyretics, analgesics, diuretics, electrolytes, physiotherapy, bedside wound opening; t2 pharmacologic including transfusion or TPN; t3 invasive procedure; t4 life-threatening ICU; t5 death); D maps disability_mrs 0-1→1, 2-3→2, 4→3, 5→4, 6→5; N is 2 if new_neurologic_deficit else 1; if therapy is t5 or disability_mrs is 6, tdn_grade is 5 (Terrapon 2021)"},{"formula":"tdn_grade","citation":{"id":"terrapon-2021","doi":"10.1093/neuros/nyab121","pmid":"33887774","title":"Adverse Events in Neurosurgery: The Novel Therapy-Disability-Neurology Grade","source":"Neurosurgery. 2021;89(2):236-245","authors":"Terrapon APR, Zattra CM, Voglis S, et al."},"criteria":[{"met":true,"value":1,"factor":"therapy"},{"met":true,"value":1,"factor":"disability"},{"met":true,"value":1,"factor":"neurology"}],"tdn_grade":1,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","therapy_grade":1,"neurology_grade":1,"disability_grade":1,"formula_expression":"tdn_grade = max(T, D, N); T is therapy t1-t5 (t1 no treatment beyond antiemetics, antipyretics, analgesics, diuretics, electrolytes, physiotherapy, bedside wound opening; t2 pharmacologic including transfusion or TPN; t3 invasive procedure; t4 life-threatening ICU; t5 death); D maps disability_mrs 0-1→1, 2-3→2, 4→3, 5→4, 6→5; N is 2 if new_neurologic_deficit else 1; if therapy is t5 or disability_mrs is 6, tdn_grade is 5 (Terrapon 2021)"}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["therapy","disability_mrs","new_neurologic_deficit"],"properties":{"therapy":{"enum":["t1","t2","t3","t4","t5"],"type":"string","description":"Terrapon 2021 Therapy dimension as assigned by the caller. t1 no treatment or intervention beyond antiemetics, antipyretics, analgesics, diuretics, electrolytes, physiotherapy, or bedside wound opening (T=1). t2 pharmacologic treatment including blood transfusion or TPN (T=2). t3 invasive procedure, surgical, endoscopic, or radiologic (T=3). t4 life-threatening, ICU management (T=4). t5 death (T=5). magent does not grade the adverse event."},"disability_mrs":{"type":"integer","description":"Modified Rankin 0-6 as assigned by the caller, including death as 6. Maps to Disability D: 0-1→1, 2-3→2, 4→3, 5→4, 6→5. This is not van Swieten 1988 modified Rankin 0-5, which omits death. magent does not interview the patient."},"new_neurologic_deficit":{"type":"boolean","description":"New neurologic deficit as assigned by the caller (Terrapon 2021 Neurology dimension). true or false. false is N=1; true is N=2. magent does not examine the patient."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Terrapon 2021 Therapy-Disability-Neurology (TDN) grade. Caller assigns therapy t1-t5, modified Rankin 0-6 (6 is death), and new neurologic deficit. Overall grade is max(T, D, N); t5 or mRS 6 is always 5. D maps mRS 0-1→1, 2-3→2, 4→3, 5→4, 6→5; new deficit is N=2 else N=1. Not a diagnosis and not Clavien-Dindo alone. magent does not grade the event.","lastUpdated":"2026-09-28T14:59:38.507Z","serviceName":"magent","x402Version":2}]}}